Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pain Relievers market report explains the definition, types, applications, major countries, and major players of the Pain Relievers market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GSK
Purdue
Merck
Reckitt Benckiser Group Plc
Eli Lilly
Allergan
Bayer
J&J
Sun Pharmaceutical
Grunenthal
AdvaCare Pharma
Novartis AG
Topical BioMedics
Sanofi
Endo
Teva
Depomed
Yunnan Baiyao
AstraZeneca
Pfizer
By Type:
Nonsteroidal Anti-inflammatory Drugs
Central Analgesics
By End-User:
Headache
Toothache
Arthralgia
Menstrual Pain
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Pain Relievers Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Pain Relievers Outlook to 2028- Original Forecasts
-
2.2 Pain Relievers Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Pain Relievers Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Pain Relievers Market- Recent Developments
-
6.1 Pain Relievers Market News and Developments
-
6.2 Pain Relievers Market Deals Landscape
7 Pain Relievers Raw Materials and Cost Structure Analysis
-
7.1 Pain Relievers Key Raw Materials
-
7.2 Pain Relievers Price Trend of Key Raw Materials
-
7.3 Pain Relievers Key Suppliers of Raw Materials
-
7.4 Pain Relievers Market Concentration Rate of Raw Materials
-
7.5 Pain Relievers Cost Structure Analysis
-
7.5.1 Pain Relievers Raw Materials Analysis
-
7.5.2 Pain Relievers Labor Cost Analysis
-
7.5.3 Pain Relievers Manufacturing Expenses Analysis
8 Global Pain Relievers Import and Export Analysis (Top 10 Countries)
-
8.1 Global Pain Relievers Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Pain Relievers Export by Region (Top 10 Countries) (2017-2028)
9 Global Pain Relievers Market Outlook by Types and Applications to 2022
-
9.1 Global Pain Relievers Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Nonsteroidal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Central Analgesics Consumption and Growth Rate (2017-2022)
-
9.2 Global Pain Relievers Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Headache Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Toothache Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Arthralgia Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Menstrual Pain Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Pain Relievers Market Analysis and Outlook till 2022
-
10.1 Global Pain Relievers Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Pain Relievers Consumption (2017-2022)
-
10.2.2 Canada Pain Relievers Consumption (2017-2022)
-
10.2.3 Mexico Pain Relievers Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Pain Relievers Consumption (2017-2022)
-
10.3.2 UK Pain Relievers Consumption (2017-2022)
-
10.3.3 Spain Pain Relievers Consumption (2017-2022)
-
10.3.4 Belgium Pain Relievers Consumption (2017-2022)
-
10.3.5 France Pain Relievers Consumption (2017-2022)
-
10.3.6 Italy Pain Relievers Consumption (2017-2022)
-
10.3.7 Denmark Pain Relievers Consumption (2017-2022)
-
10.3.8 Finland Pain Relievers Consumption (2017-2022)
-
10.3.9 Norway Pain Relievers Consumption (2017-2022)
-
10.3.10 Sweden Pain Relievers Consumption (2017-2022)
-
10.3.11 Poland Pain Relievers Consumption (2017-2022)
-
10.3.12 Russia Pain Relievers Consumption (2017-2022)
-
10.3.13 Turkey Pain Relievers Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Pain Relievers Consumption (2017-2022)
-
10.4.2 Japan Pain Relievers Consumption (2017-2022)
-
10.4.3 India Pain Relievers Consumption (2017-2022)
-
10.4.4 South Korea Pain Relievers Consumption (2017-2022)
-
10.4.5 Pakistan Pain Relievers Consumption (2017-2022)
-
10.4.6 Bangladesh Pain Relievers Consumption (2017-2022)
-
10.4.7 Indonesia Pain Relievers Consumption (2017-2022)
-
10.4.8 Thailand Pain Relievers Consumption (2017-2022)
-
10.4.9 Singapore Pain Relievers Consumption (2017-2022)
-
10.4.10 Malaysia Pain Relievers Consumption (2017-2022)
-
10.4.11 Philippines Pain Relievers Consumption (2017-2022)
-
10.4.12 Vietnam Pain Relievers Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Pain Relievers Consumption (2017-2022)
-
10.5.2 Colombia Pain Relievers Consumption (2017-2022)
-
10.5.3 Chile Pain Relievers Consumption (2017-2022)
-
10.5.4 Argentina Pain Relievers Consumption (2017-2022)
-
10.5.5 Venezuela Pain Relievers Consumption (2017-2022)
-
10.5.6 Peru Pain Relievers Consumption (2017-2022)
-
10.5.7 Puerto Rico Pain Relievers Consumption (2017-2022)
-
10.5.8 Ecuador Pain Relievers Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Pain Relievers Consumption (2017-2022)
-
10.6.2 Kuwait Pain Relievers Consumption (2017-2022)
-
10.6.3 Oman Pain Relievers Consumption (2017-2022)
-
10.6.4 Qatar Pain Relievers Consumption (2017-2022)
-
10.6.5 Saudi Arabia Pain Relievers Consumption (2017-2022)
-
10.6.6 United Arab Emirates Pain Relievers Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Pain Relievers Consumption (2017-2022)
-
10.7.2 South Africa Pain Relievers Consumption (2017-2022)
-
10.7.3 Egypt Pain Relievers Consumption (2017-2022)
-
10.7.4 Algeria Pain Relievers Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Pain Relievers Consumption (2017-2022)
-
10.8.2 New Zealand Pain Relievers Consumption (2017-2022)
11 Global Pain Relievers Competitive Analysis
-
11.1 GSK
-
11.1.1 GSK Company Details
-
11.1.2 GSK Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GSK Pain Relievers Main Business and Markets Served
-
11.1.4 GSK Pain Relievers Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Purdue
-
11.2.1 Purdue Company Details
-
11.2.2 Purdue Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Purdue Pain Relievers Main Business and Markets Served
-
11.2.4 Purdue Pain Relievers Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Merck
-
11.3.1 Merck Company Details
-
11.3.2 Merck Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Merck Pain Relievers Main Business and Markets Served
-
11.3.4 Merck Pain Relievers Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Reckitt Benckiser Group Plc
-
11.4.1 Reckitt Benckiser Group Plc Company Details
-
11.4.2 Reckitt Benckiser Group Plc Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Reckitt Benckiser Group Plc Pain Relievers Main Business and Markets Served
-
11.4.4 Reckitt Benckiser Group Plc Pain Relievers Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Eli Lilly
-
11.5.1 Eli Lilly Company Details
-
11.5.2 Eli Lilly Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Eli Lilly Pain Relievers Main Business and Markets Served
-
11.5.4 Eli Lilly Pain Relievers Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Allergan
-
11.6.1 Allergan Company Details
-
11.6.2 Allergan Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Allergan Pain Relievers Main Business and Markets Served
-
11.6.4 Allergan Pain Relievers Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bayer
-
11.7.1 Bayer Company Details
-
11.7.2 Bayer Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bayer Pain Relievers Main Business and Markets Served
-
11.7.4 Bayer Pain Relievers Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 J&J
-
11.8.1 J&J Company Details
-
11.8.2 J&J Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 J&J Pain Relievers Main Business and Markets Served
-
11.8.4 J&J Pain Relievers Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Sun Pharmaceutical
-
11.9.1 Sun Pharmaceutical Company Details
-
11.9.2 Sun Pharmaceutical Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Sun Pharmaceutical Pain Relievers Main Business and Markets Served
-
11.9.4 Sun Pharmaceutical Pain Relievers Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Grunenthal
-
11.10.1 Grunenthal Company Details
-
11.10.2 Grunenthal Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Grunenthal Pain Relievers Main Business and Markets Served
-
11.10.4 Grunenthal Pain Relievers Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 AdvaCare Pharma
-
11.11.1 AdvaCare Pharma Company Details
-
11.11.2 AdvaCare Pharma Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 AdvaCare Pharma Pain Relievers Main Business and Markets Served
-
11.11.4 AdvaCare Pharma Pain Relievers Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Novartis AG
-
11.12.1 Novartis AG Company Details
-
11.12.2 Novartis AG Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Novartis AG Pain Relievers Main Business and Markets Served
-
11.12.4 Novartis AG Pain Relievers Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Topical BioMedics
-
11.13.1 Topical BioMedics Company Details
-
11.13.2 Topical BioMedics Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Topical BioMedics Pain Relievers Main Business and Markets Served
-
11.13.4 Topical BioMedics Pain Relievers Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Sanofi
-
11.14.1 Sanofi Company Details
-
11.14.2 Sanofi Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Sanofi Pain Relievers Main Business and Markets Served
-
11.14.4 Sanofi Pain Relievers Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Endo
-
11.15.1 Endo Company Details
-
11.15.2 Endo Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Endo Pain Relievers Main Business and Markets Served
-
11.15.4 Endo Pain Relievers Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Teva
-
11.16.1 Teva Company Details
-
11.16.2 Teva Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Teva Pain Relievers Main Business and Markets Served
-
11.16.4 Teva Pain Relievers Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Depomed
-
11.17.1 Depomed Company Details
-
11.17.2 Depomed Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Depomed Pain Relievers Main Business and Markets Served
-
11.17.4 Depomed Pain Relievers Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Yunnan Baiyao
-
11.18.1 Yunnan Baiyao Company Details
-
11.18.2 Yunnan Baiyao Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Yunnan Baiyao Pain Relievers Main Business and Markets Served
-
11.18.4 Yunnan Baiyao Pain Relievers Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 AstraZeneca
-
11.19.1 AstraZeneca Company Details
-
11.19.2 AstraZeneca Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 AstraZeneca Pain Relievers Main Business and Markets Served
-
11.19.4 AstraZeneca Pain Relievers Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Pfizer
-
11.20.1 Pfizer Company Details
-
11.20.2 Pfizer Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Pfizer Pain Relievers Main Business and Markets Served
-
11.20.4 Pfizer Pain Relievers Product Portfolio
-
11.20.5 Recent Research and Development Strategies
12 Global Pain Relievers Market Outlook by Types and Applications to 2028
-
12.1 Global Pain Relievers Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Nonsteroidal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Central Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Pain Relievers Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Headache Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Toothache Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Arthralgia Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Menstrual Pain Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Pain Relievers Market Analysis and Outlook to 2028
-
13.1 Global Pain Relievers Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Pain Relievers Consumption Forecast (2022-2028)
-
13.2.2 Canada Pain Relievers Consumption Forecast (2022-2028)
-
13.2.3 Mexico Pain Relievers Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Pain Relievers Consumption Forecast (2022-2028)
-
13.3.2 UK Pain Relievers Consumption Forecast (2022-2028)
-
13.3.3 Spain Pain Relievers Consumption Forecast (2022-2028)
-
13.3.4 Belgium Pain Relievers Consumption Forecast (2022-2028)
-
13.3.5 France Pain Relievers Consumption Forecast (2022-2028)
-
13.3.6 Italy Pain Relievers Consumption Forecast (2022-2028)
-
13.3.7 Denmark Pain Relievers Consumption Forecast (2022-2028)
-
13.3.8 Finland Pain Relievers Consumption Forecast (2022-2028)
-
13.3.9 Norway Pain Relievers Consumption Forecast (2022-2028)
-
13.3.10 Sweden Pain Relievers Consumption Forecast (2022-2028)
-
13.3.11 Poland Pain Relievers Consumption Forecast (2022-2028)
-
13.3.12 Russia Pain Relievers Consumption Forecast (2022-2028)
-
13.3.13 Turkey Pain Relievers Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Pain Relievers Consumption Forecast (2022-2028)
-
13.4.2 Japan Pain Relievers Consumption Forecast (2022-2028)
-
13.4.3 India Pain Relievers Consumption Forecast (2022-2028)
-
13.4.4 South Korea Pain Relievers Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Pain Relievers Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Pain Relievers Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Pain Relievers Consumption Forecast (2022-2028)
-
13.4.8 Thailand Pain Relievers Consumption Forecast (2022-2028)
-
13.4.9 Singapore Pain Relievers Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Pain Relievers Consumption Forecast (2022-2028)
-
13.4.11 Philippines Pain Relievers Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Pain Relievers Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Pain Relievers Consumption Forecast (2022-2028)
-
13.5.2 Colombia Pain Relievers Consumption Forecast (2022-2028)
-
13.5.3 Chile Pain Relievers Consumption Forecast (2022-2028)
-
13.5.4 Argentina Pain Relievers Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Pain Relievers Consumption Forecast (2022-2028)
-
13.5.6 Peru Pain Relievers Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Pain Relievers Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Pain Relievers Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Pain Relievers Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Pain Relievers Consumption Forecast (2022-2028)
-
13.6.3 Oman Pain Relievers Consumption Forecast (2022-2028)
-
13.6.4 Qatar Pain Relievers Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Pain Relievers Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Pain Relievers Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Pain Relievers Consumption Forecast (2022-2028)
-
13.7.2 South Africa Pain Relievers Consumption Forecast (2022-2028)
-
13.7.3 Egypt Pain Relievers Consumption Forecast (2022-2028)
-
13.7.4 Algeria Pain Relievers Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Pain Relievers Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Pain Relievers Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Pain Relievers
-
Figure of Pain Relievers Picture
-
Table Global Pain Relievers Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Pain Relievers Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Nonsteroidal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Central Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Headache Consumption and Growth Rate (2017-2022)
-
Figure Global Toothache Consumption and Growth Rate (2017-2022)
-
Figure Global Arthralgia Consumption and Growth Rate (2017-2022)
-
Figure Global Menstrual Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Pain Relievers Consumption by Country (2017-2022)
-
Table North America Pain Relievers Consumption by Country (2017-2022)
-
Figure United States Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Canada Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Mexico Pain Relievers Consumption and Growth Rate (2017-2022)
-
Table Europe Pain Relievers Consumption by Country (2017-2022)
-
Figure Germany Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure UK Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Spain Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Belgium Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure France Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Italy Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Denmark Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Finland Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Norway Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Sweden Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Poland Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Russia Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Turkey Pain Relievers Consumption and Growth Rate (2017-2022)
-
Table APAC Pain Relievers Consumption by Country (2017-2022)
-
Figure China Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Japan Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure India Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Thailand Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Singapore Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Philippines Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Pain Relievers Consumption and Growth Rate (2017-2022)
-
Table South America Pain Relievers Consumption by Country (2017-2022)
-
Figure Brazil Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Colombia Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Chile Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Argentina Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Peru Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Pain Relievers Consumption and Growth Rate (2017-2022)
-
Table GCC Pain Relievers Consumption by Country (2017-2022)
-
Figure Bahrain Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Oman Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Qatar Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Pain Relievers Consumption and Growth Rate (2017-2022)
-
Table Africa Pain Relievers Consumption by Country (2017-2022)
-
Figure Nigeria Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure South Africa Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Egypt Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure Algeria Pain Relievers Consumption and Growth Rate (2017-2022)
-
Table Oceania Pain Relievers Consumption by Country (2017-2022)
-
Figure Australia Pain Relievers Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Pain Relievers Consumption and Growth Rate (2017-2022)
-
Table GSK Company Details
-
Table GSK Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Pain Relievers Main Business and Markets Served
-
Table GSK Pain Relievers Product Portfolio
-
Table Purdue Company Details
-
Table Purdue Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Pain Relievers Main Business and Markets Served
-
Table Purdue Pain Relievers Product Portfolio
-
Table Merck Company Details
-
Table Merck Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Pain Relievers Main Business and Markets Served
-
Table Merck Pain Relievers Product Portfolio
-
Table Reckitt Benckiser Group Plc Company Details
-
Table Reckitt Benckiser Group Plc Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reckitt Benckiser Group Plc Pain Relievers Main Business and Markets Served
-
Table Reckitt Benckiser Group Plc Pain Relievers Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Pain Relievers Main Business and Markets Served
-
Table Eli Lilly Pain Relievers Product Portfolio
-
Table Allergan Company Details
-
Table Allergan Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Pain Relievers Main Business and Markets Served
-
Table Allergan Pain Relievers Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Pain Relievers Main Business and Markets Served
-
Table Bayer Pain Relievers Product Portfolio
-
Table J&J Company Details
-
Table J&J Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table J&J Pain Relievers Main Business and Markets Served
-
Table J&J Pain Relievers Product Portfolio
-
Table Sun Pharmaceutical Company Details
-
Table Sun Pharmaceutical Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Pain Relievers Main Business and Markets Served
-
Table Sun Pharmaceutical Pain Relievers Product Portfolio
-
Table Grunenthal Company Details
-
Table Grunenthal Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grunenthal Pain Relievers Main Business and Markets Served
-
Table Grunenthal Pain Relievers Product Portfolio
-
Table AdvaCare Pharma Company Details
-
Table AdvaCare Pharma Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table AdvaCare Pharma Pain Relievers Main Business and Markets Served
-
Table AdvaCare Pharma Pain Relievers Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Pain Relievers Main Business and Markets Served
-
Table Novartis AG Pain Relievers Product Portfolio
-
Table Topical BioMedics Company Details
-
Table Topical BioMedics Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Topical BioMedics Pain Relievers Main Business and Markets Served
-
Table Topical BioMedics Pain Relievers Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pain Relievers Main Business and Markets Served
-
Table Sanofi Pain Relievers Product Portfolio
-
Table Endo Company Details
-
Table Endo Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo Pain Relievers Main Business and Markets Served
-
Table Endo Pain Relievers Product Portfolio
-
Table Teva Company Details
-
Table Teva Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pain Relievers Main Business and Markets Served
-
Table Teva Pain Relievers Product Portfolio
-
Table Depomed Company Details
-
Table Depomed Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Depomed Pain Relievers Main Business and Markets Served
-
Table Depomed Pain Relievers Product Portfolio
-
Table Yunnan Baiyao Company Details
-
Table Yunnan Baiyao Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yunnan Baiyao Pain Relievers Main Business and Markets Served
-
Table Yunnan Baiyao Pain Relievers Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Pain Relievers Main Business and Markets Served
-
Table AstraZeneca Pain Relievers Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Pain Relievers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pain Relievers Main Business and Markets Served
-
Table Pfizer Pain Relievers Product Portfolio
-
Figure Global Nonsteroidal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Headache Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Toothache Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Arthralgia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Menstrual Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain Relievers Consumption Forecast by Country (2022-2028)
-
Table North America Pain Relievers Consumption Forecast by Country (2022-2028)
-
Figure United States Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pain Relievers Consumption Forecast by Country (2022-2028)
-
Figure Germany Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Pain Relievers Consumption Forecast by Country (2022-2028)
-
Figure China Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Pain Relievers Consumption Forecast by Country (2022-2028)
-
Figure Brazil Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Pain Relievers Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Pain Relievers Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Pain Relievers Consumption Forecast by Country (2022-2028)
-
Figure Australia Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Pain Relievers Consumption Forecast and Growth Rate (2022-2028)
-
